48,830
edits
(→Human papilloma virus: +vaccine) |
|||
Line 77: | Line 77: | ||
*HPV 16 - predominantly squamous cell carcinoma.<ref name=pmid15551313/> | *HPV 16 - predominantly squamous cell carcinoma.<ref name=pmid15551313/> | ||
Recombinant vaccine (Gardasil, Silgard) - | Recombinant vaccine (Gardasil, Silgard) - covers:<ref name=pmid21942919>{{Cite journal | last1 = McCormack | first1 = PL. | last2 = Joura | first2 = EA. | title = Spotlight on Quadrivalent Human Papillomavirus(Types 6, 11, 16, 18) Recombinant Vaccine(Gardasil®) in the Prevention of PremalignantGenital Lesions, Genital Cancer, and Genital Warts in Women†. | journal = BioDrugs | volume = 25 | issue = 5 | pages = 339-43 | month = Oct | year = 2011 | doi = 10.2165/11205060-000000000-00000 | PMID = 21942919 }}</ref> | ||
*HPV 6. | *HPV 6. | ||
*HPV 11. | *HPV 11. |
edits